These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 32292848)

  • 1. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies.
    Atri D; Siddiqi HK; Lang JP; Nauffal V; Morrow DA; Bohula EA
    JACC Basic Transl Sci; 2020 May; 5(5):518-536. PubMed ID: 32292848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 and cardiovascular system: A narrative review.
    Kwenandar F; Japar KV; Damay V; Hariyanto TI; Tanaka M; Lugito NPH; Kurniawan A
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100557. PubMed ID: 32550259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection and smoking: What is the association? A brief review.
    Gupta I; Sohail MU; Elzawawi KE; Amarah AH; Vranic S; Al-Asmakh M; Al Moustafa AE
    Comput Struct Biotechnol J; 2021; 19():1654-1660. PubMed ID: 33777332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and Kidney Disease: Update on Epidemiology, Clinical Manifestations, Pathophysiology and Management.
    Asgharpour M; Zare E; Mubarak M; Alirezaei A
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):19-25. PubMed ID: 32723443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and COVID-19: Global and regional perspectives.
    Jeong IK; Yoon KH; Lee MK
    Diabetes Res Clin Pract; 2020 Aug; 166():108303. PubMed ID: 32623038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019.
    Pan F; Xiao X; Guo J; Song Y; Li H; Patel DP; Spivak AM; Alukal JP; Zhang X; Xiong C; Li PS; Hotaling JM
    Fertil Steril; 2020 Jun; 113(6):1135-1139. PubMed ID: 32482249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SARS-CoV-2 on Male Reproductive Health: A Review of the Literature on Male Reproductive Involvement in COVID-19.
    He W; Liu X; Feng L; Xiong S; Li Y; Chen L; Li Y; Wang G; Li D; Fu B
    Front Med (Lausanne); 2020; 7():594364. PubMed ID: 33330557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection.
    Soheili M; Haji-Allahverdipoor K; Khadem-Erfan MB; Baban B; Nikkhoo B; Eliasi A; Nasseri S
    Med J Islam Repub Iran; 2020; 34():120. PubMed ID: 33316002
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.
    Beeraka NM; Sadhu SP; Madhunapantula SV; Rao Pragada R; Svistunov AA; Nikolenko VN; Mikhaleva LM; Aliev G
    Front Immunol; 2020; 11():552925. PubMed ID: 33072093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.
    Yamamoto M; Kiso M; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Imai M; Takeda M; Kinoshita N; Ohmagari N; Gohda J; Semba K; Matsuda Z; Kawaguchi Y; Kawaoka Y; Inoue JI
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019.
    Zhu C; Sun B; Zhang X; Zhang B
    Front Pharmacol; 2020; 11():1327. PubMed ID: 32973534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
    Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.